Skye Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	12,650	-	-	-	-	-	-	-
Enterprise Value	12,527	-6	1	-7	-1	-1	-0	-0
EV/EBITDA Ratio	0.16	0.16	-0.04	0.89	0.17	-0.70	0.03	0.01
EV/EBIT Ratio	0.16	0.16	-0.04	0.88	0.17	-0.70	0.03	0.01
EV/FCF Ratio	0.41	0.41	-0.05	1.04	0.16	0.24	0.13	0.01
Debt / Equity Ratio	-2.16	-2.16	-0.64	0.36	3.32	0.71	-0.09	-0.07
Debt / EBITDA Ratio	-0.13	-0.13	-0.10	-0.28	-0.26	0.19	-0.07	-0.08
Debt / FCF Ratio	-0.33	-0.33	-0.15	-0.33	-0.25	-0.06	-0.34	-0.07
Quick Ratio	0.74	0.74	0.10	2.30	3.14	1.89	0.12	0.33
Current Ratio	0.84	0.84	0.74	2.46	3.39	2.06	0.12	0.69
Interest Coverage	-40.53	-40.53	-28.28	-10.08	-8.29	2.05	-201.53	-4635.73
Return on Equity (ROE)	1157.70%	1157.70%	2151.60%	-180.60%	1052.60%	-7.60%	193.30%	131.30%
Return on Assets (ROA)	-438.10%	-438.10%	-322.60%	-105.10%	-331.30%	36.50%	-922.40%	-827.00%
Return on Capital (ROIC)	-1398.67%	-1398.67%	1694.00%	-98.09%	-322.75%	-708.19%	33.04%	115.74%
Earnings Yield	-0.30%	-	-	-	-	-	-	-
FCF Yield	-0.11%	-	-	-	-	-	-	-
Buyback Yield / Dilution	-215.43%	-215.43%	-36.56%	-75.70%	-36.48%	-39.95%	-334.15%	-47.28%
Total Shareholder Return	-215.43%	-215.43%	-36.56%	-75.70%	-36.48%	-39.95%	-334.15%	-47.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).